CADASIL is one of the most common genetic causes of stroke and dementia. Currently there is no treatment for CADASIL. In this study, human stem cells will be generated from a piece of skin donated by patients with CADASIL. From these stem cells, smooth muscle cells (SMCs) will be generated in a tissue culture dish in the lab.
Our new report, ‘Current, future and avoidable costs of stroke in the UK’, suggests that investing in stroke research today could lead to a significant reduction in the burden of stroke in the future.
We need your support to continue to invest in research that will help to save lives and enable stroke survivors to make the best possible recovery.
Stroke is the biggest cause of complex disability worldwide, with an estimated 1.2 million stroke survivors in the UK today. Living with the long term impact of the condition can be devastating, yet research funding dedicated to stroke remains disproportionately small. With an ageing population, the burden of stroke is set to rise.
Today, the Association of Medical Research Charities (AMRC) launched a new spotlight report highlighting the positive difference medical research charities are making for mental health patients across the UK.
The Stroke Association's Keynote Lecture is a prestigious event that showcases the latest advancements being made in stroke research.
Find out more about our Keynote Lecture 2015
Project Grants are our most popular funding stream and cover the whole spectrum of stroke research - from prevention and risk factors, through to treatment and rehabilitation in a clinical setting and longer-term in the community. Find out more about our project grants awarded for 2016.